4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-056913
Director sold 3,556 shares at $29.06 ($103,337)
From the SEC's structured data for this filing
Trades in this filing
GADICKE ANSBERT · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-16 | Sale : show line 1 in the form | −432 | $29.06 | $12,554 | 244,551 | D |
| 2021-09-16 | Sale : show line 2 in the form | −3,124 | $29.06 | $90,783 | 7,648,268 | I |
| Open-market sales · 3,556 sh · avg $29.06 · $103,337 | ||||||
Loading xslF345X03/doc4.xml…